Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Clovis Oncology Inc (NQ: CLVS )

5.580 USD -0.080 (-1.41%)
Official Closing Price Updated: 7:59 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,720,100
Open 5.670
Bid (Size) 5.520 (5)
Ask (Size) 5.590 (9)
Prev. Close 5.660
Today's Range 5.040 - 5.780
52wk Range 3.620 - 11.10
Shares Outstanding 52,548,995
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Extensive Demand for T-Cell Adoptive Immunotherapy Rising with Growing Prevalence of Cancer
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Extensive Demand for T-Cell Adoptive Immunotherapy Rising with Growing Prevalence of Cancer
- Financialnewsmedia.com News Commentary 
From PR Newswire

Performance

YTD
+16.01%
+16.01%
1 Month
-30.16%
-30.16%
3 Month
+8.98%
+8.98%
6 Month
+7.72%
+7.72%
1 Year
-29.01%
-29.01%

More News

Read More
Clovis Oncology Announces 2020 Operating Results
From Business Wire News Releases
April 23rd Options Now Available For Clovis Oncology (CLVS)
Tags Stocks
From Market News Video
Understanding Clovis Oncology's Unusual Options Activity
Tags Benzinga CLVS BZI/UOA
From Benzinga
Clovis Oncology to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Webcast Conference Call on February 23
From Business Wire News Releases
Clovis Oncology: Q4 Earnings Insights
Tags Market News Benzinga Earnings
From Benzinga
Thinking about buying stock in Workhorse Group, Sundial Growers, Nokia, Clovis Oncology, or Compugen?
From PR Newswire
Clovis Oncology Presents Data in Advanced Prostate Cancer at ASCO 2021 Genitourinary Cancers Symposium Virtual Meeting
From Business Wire News Releases
Earnings Preview for Clovis Oncology
Tags Market News CLVS Earnings
From Benzinga
3 Troll-able Stocks That Could Be the Next GME
Tags NASDAQ:CLVS,NASDAQ:NAKD,NASDAQ:PGEN,NYSE:GME,NYSE:C GME CLVS
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.